NASDAQ
Freeline Therapeutics Holdings plc (FRLN) has a current ratio of 2.18x as of Monday, May 25, 2026. This represents a 70.82% decrease compared to its 12-month average of 7.48x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.